Skip to content

Correction of Asymptomatic 2nd Degree Cystocele in Patient With Stress Incontinence

Is There Any Value of Concomitant Repair of Asymptomatic Grade II Anterior Vaginal Wall Prolapse During Mid Urethral Sling Surgery for Stress Urinary Incontinence ?

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03296748
Enrollment
123
Registered
2017-09-28
Start date
2016-06-01
Completion date
2017-09-30
Last updated
2017-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Keywords

asymptomatic cystocele., stress urinary incontinence

Brief summary

The aim of our study is to assess the value of concomitant surgical correction of asymptomatic grade II anterior vaginal wall prolapse with the placement of midurethral sling for treatment of female patients with stress incontinence

Detailed description

female patients with stress urinary incontinence and asymptomatic grade II anterior vaginal wall prolapse were divided into Group A: treated only with trans-obturator tape (TOT) and group B where' TOT was associated with anterior colporrhaphy and the outcome is compared.

Interventions

PROCEDUREtrans-obturator tape inside-out usingsoft tapes.

trans-obturator tape inside-out soft tapes is applied under spinal anesthesia. After the procedure, the vaginal gauze packing and Foley catheter were removed on the morning of the next day.

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

female patients with stress urinary incontinence and asymptomatic grade II anterior vaginal wall prolapse were divided into Group A: treated only with trans-obturator tape (TOT) and group B where' TOT was associated with anterior colporrhaphy .

Eligibility

Sex/Gender
FEMALE
Age
23 Years to 56 Years
Healthy volunteers
No

Inclusion criteria

* female patients * genuine stress incontinence * asymptomatic cystocele

Exclusion criteria

* mixed incontinence

Design outcomes

Primary

MeasureTime frameDescription
cure rate of stress incontinence3 months after surgeryby clinical assessment
Denovo urgency3 months after surgeryby clinical assessment

Secondary

MeasureTime frameDescription
cure rate of stress incontinence6 months after surgeryby clinical assessment
Denovo urgency6 months after surgeryby clinical assessment

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026